‘United, we set the terms’: Parliament pushes Europe to stand up to US drug pricing

EU PERSPECTIVES - As US drug pricing policy raises concerns over Europe's access to new medicines, lawmakers are urging member states to pool their bargaining power. The biotech industry, however, sees the pressure from Washington as a short-term shock and wants Europe to focus on its own competitiveness. Read more

New medicine launches across Europe fell by 35% in the 10 months after MFN started / Photo: Unsplash